Fatty liver

Trouble in Paradise – 12.21.22

/ SupremeCmdr / Leave a comment

An analysis of current drinkers in the Framingham Heart Study found that a higher number of drinks per week and higher frequency of drinking were associated with increased odds of fibrosis among patients whose consumption fell below the threshold for heavy alcohol use.

Non-Heavy Alcohol Use Associated With Liver Fibrosis, NASH – Medscape – Dec 21, 2022 – https://www.medscape.com/viewarticle/985950?src=rss#vp_1

Oh crap.

I better read the full study.

Non-heavy alcohol use associates with liver fibrosis and ‘nonalcoholic’ steatohepatitis in the Framingham Heart Study – DOI:https://doi.org/10.1016/j.cgh.2022.10.039

Fatty Liver = Increased DM2 Risk

/ SupremeCmdr / Leave a comment

Fatty liver increases risk for type 2 diabetes

“Individuals with fatty liver are five times more likely to develop type 2 diabetes then those without fatty liver, researchers have found. This increased risk occurred regardless of the patient’s fasting insulin levels, which were used as a marker of insulin resistance in the study” 

Fatty Liver Matters

/ SupremeCmdr / Leave a comment

Please tell me you already knew this.

Medical News: Fatty Liver Raises Risk of Death – in Gastroenterology, General Hepatology from MedPage Today

People with non-alcoholic fatty liver disease (NAFLD), a condition that often accompanies obesity and type 2 diabetes, have higher mortality rates than the general population, a new Swedish study found.

Patients with NAFLD were 69% percent more likely to die than the general Swedish population (standardized mortality ratio 1.69, 95% CI 1.24 to 2.25), according to a report in the February issue of Hepatology.

Patients with non-alcoholic steatohepatitis (NASH), a condition where fat buildup causes liver inflammation, were at 86% higher risk (95% CI 1.19 to 2.76; P=0.007).